Adherence to oral endocrine treatments in women with breast cancer: can it be improved? - Wikidata - wikimedia - TriplyDB

Adherence to oral endocrine treatments in women with breast cancer: can it be improved?

Adherence to oral endocrine treatments in women with breast cancer: can it be improved?

http://www.wikidata.org/entity/Q37877172

about

Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review Ethnic disparities in adherence to breast cancer survivorship surveillance care.Early discontinuation of adjuvant hormone therapy is associated with a poor prognosis in Japanese breast cancer patients.Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.Barriers and facilitators to endocrine therapy adherence among underserved hormone-receptor-positive breast cancer survivors: a qualitative study.Socio-demographic and geographic variations in the utilization of hormone therapy in older women with breast cancer after Medicare Part-D coverage.Prevalence and Determinants of Adherence to Oral Adjuvant Endocrine Therapy among Breast Cancer Patients in Singapore.Factors influencing the process of medication (non-)adherence and (non-)persistence in breast cancer patients with adjuvant antihormonal therapy: a qualitative study.

P2860

Q28082674-4CD027E1-A60F-4602-AC2F-F071766CA7B3 Q34025681-EBCD8216-45FC-4B9A-9654-1DCBC96C1953 Q34174599-D1CA61E1-B65F-4442-A79F-0CE445F17242 Q36713559-A22EDF40-3B84-4A87-88B1-89E4B0A97AFD Q39794191-E5E45BA4-DF8D-4F31-BDB2-2DE97CBA4DE4 Q41120416-C077463E-1CEA-4747-8A3F-60F3FC77A8FF Q42131354-61C9E2AD-CC10-4FDD-836B-90E0FE74920F Q49133615-E3357785-6943-4C51-A5A1-7DEE4F094CE8

P2860

Adherence to oral endocrine treatments in women with breast cancer: can it be improved?

http://www.wikidata.org/entity/Q37877172

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 May 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Adherence to oral endocrine treatments in women with breast cancer: can it be improved?

@en

Adherence to oral endocrine treatments in women with breast cancer: can it be improved?

@nl

type

label

Adherence to oral endocrine treatments in women with breast cancer: can it be improved?

@en

Adherence to oral endocrine treatments in women with breast cancer: can it be improved?

@nl

prefLabel

Adherence to oral endocrine treatments in women with breast cancer: can it be improved?

@en

Adherence to oral endocrine treatments in women with breast cancer: can it be improved?

@nl

P1433

Q37877172-FF62901A-44A3-467C-AC71-17C2A06A9518

P1476

Q37877172-923689FD-1A86-4AD2-918C-3A8BCAC38DF3

P2093

Q37877172-6BA19A9C-0583-4345-BAAC-77F2CBD146DE

P2860

Q37877172-09A58DF9-516C-4510-B102-E89578A9C09B

Q37877172-0D8F913F-4439-4843-922E-4337AB590C33

Q37877172-0F8E15A2-1C52-4A22-AC99-AC69D8CFB7D8

Q37877172-126B839D-A277-4A3C-A93F-6D3693506185

Q37877172-129724BB-D127-4326-B77B-FCE41229C271

Q37877172-1342DB8E-0644-48C3-9F61-2A71CCA1D6EF

Q37877172-1A6F943C-EF44-47AF-ABE9-9946EA1FA6F6

Q37877172-1B888185-D230-4C41-92C4-8A5E80E6BD6D

Q37877172-1E75C58E-B6F1-474D-9346-109596B7C70B

Q37877172-1F239DB4-6FEE-46AB-B7A3-7CA0734B2602

P2888

Q37877172-C235BEEA-6DD1-437E-89C0-E8EB4AFC4686

P304

Q37877172-57C534DF-ED54-4B59-8AC3-A3A0AB91DD41

P31

Q37877172-818C364C-E073-4E47-90D1-5AACE4352BB6

P356

Q37877172-4D742C14-0D7A-47EA-B41F-BA02A7A2D96D

P407

Q37877172-3868EBF0-01D9-4AC2-A8A4-9DAC8545A6CF

P433

Q37877172-DD7E0119-4799-4449-B8B5-F2CCB83141F3

P478

Q37877172-DB2E6D4A-C2AE-4211-BE32-03D3A93E1CE9

P577

Q37877172-18622442-9C72-462F-9EF1-FB2ACA4F7A2A

P698

Q37877172-052BC9C4-2188-4B76-A845-7C9F31B6E82D

P356

S10549-011-1578-Z

P1433

Breast Cancer Research and Treatment

P1476

Adherence to oral endocrine treatments in women with breast cancer: can it be improved?

@en

P2093

Sheila A Doggrell

http://www.w3.org/2001/XMLSchema#string

P2860

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study

Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)--a randomised controlled trial of exemestane versus continued tamoxifen after 2-3 years tamoxifen.

Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial.

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients

Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer.

Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients

Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.

Hormone-replacement therapy and breast cancer.

P2888

s10549-011-1578-z

P304

299-308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-011-1578-Z

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21594663

http://www.w3.org/2001/XMLSchema#string